Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival (Q56944494)

From Wikidata

Jump to navigation Jump to search

article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology

Language	Label	Description	Also known as
English	Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival	article by Albert W Chan et al published October 2003 in Journal of the American College of Cardiology

Statements

scholarly article

0 references

Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival (English)

0 references

object named as

Eric J Topol

10

0 references

David J Moliterno

2

object named as

David J Moliterno

0 references

Deepak L. Bhatt

9

object named as

Deepak L Bhatt

0 references

Peter B. Berger

3

object named as

Peter B Berger

0 references

4

object named as

Gregg W Stone

0 references

8

object named as

Kathy Wolski

0 references

Steven J Yakubov

6

object named as

Steven L Yakubov

0 references

Peter M DiBattiste

5

object named as

Peter M DiBattiste

0 references

7

object named as

Shelly K Sapp

0 references

author name string

Albert W Chan

1

0 references

language of work or name

0 references

publication date

October 2003

0 references

Journal of the American College of Cardiology

0 references

42

0 references

7

0 references

1188-1195

0 references

Aspirin and dipyridamole in the prevention of acute coronary thrombosis complicating coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of thromboxane A2 blockade on clinical outcome and restenosis after successful coronary angioplasty. Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: the multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Sustained benefit over four years from an initial combined antiplatelet regimen after coronary stent placement in the ISAR trial. Intracoronary Stenting and Antithrombotic Regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of thrombotic occlusion and major adverse cardiac events between two and four weeks after coronary stent placement: analysis of 5,678 patients with a four-week ticlopidine regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events: data from the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific impairment of human platelet P2Y(AC) ADP receptor-mediated signaling by the antiplatelet drug clopidogrel

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel versus ticlopidine after intracoronary stent placement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting : the clopidogrel aspirin stent international cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A direct comparison of tirofiban and abciximab during percutaneous coronary revascularization and stent placement: Rationale and design of the TARGET study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of clopidogrel pretreatment before percutaneous coronary intervention in patients treated with glycoprotein IIb/IIIa inhibitors (abciximab or tirofiban).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet glycoprotein IIb/IIIa inhibitors: recognition of a two-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of ICHOR-platelet works to assess platelet function in patients treated with GP IIb/IIIa inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative study of light transmission aggregometry and automated bedside platelet function assays in patients undergoing percutaneous coronary intervention and receiving abciximab, eptifibatide, or tirofiban

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2803%2900944-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(03)00944-6

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56944494&oldid=1746190723"